Capsida Biotherapeutics

Newbury Park, United States

Capsida Biotherapeutics is a biotechnology company that specializes in tackling monogenetic and sporadic CNS and non-CNS disorders.

Feb 2023

Corporate Round

Biotechnology Genetics Health Care

Top Investors

AbbVieVersant VenturesWestlake Village BioPartners

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Capsida Biotherapeutics

Who are Capsida Biotherapeutics's investors?

Capsida Biotherapeutics's investors include AbbVie, Versant Ventures, Westlake Village BioPartners.

Where is Capsida Biotherapeutics headquartered?

Capsida Biotherapeutics is headquartered in Newbury Park, United States.

What does Capsida Biotherapeutics do?

Capsida Biotherapeutics is a biotechnology company that specializes in tackling monogenetic and sporadic CNS and non-CNS disorders.

What stage is Capsida Biotherapeutics at?

Capsida Biotherapeutics is at the Corporate Round stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated February 23, 2023.

MLA

"Capsida Biotherapeutics — Funding & Investors." VCBacked, February 23, 2023, https://www.vcbacked.co/company/capsida-biotherapeutics. Accessed July 1, 2026.

APA

VCBacked. (2023). Capsida Biotherapeutics — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/capsida-biotherapeutics

Wikipedia (cite web)

{{cite web |title=Capsida Biotherapeutics — Funding & Investors |url=https://www.vcbacked.co/company/capsida-biotherapeutics |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated February 23, 2023.